載入...
Long-term Tolvaptan Treatment of Autosomal Dominant Polycystic Kidney Disease in Korea
A 22-year-old male patient was diagnosed with autosomal dominant polycystic kidney disease (ADPKD). He received conservative treatment with an angiotensin-converting enzyme inhibitor. Two years later, oral therapy, consisting of 60 mg tolvaptan per day, was initiated. Compared with height-adjusted t...
Na minha lista:
| 發表在: | Electrolyte Blood Press |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The Korean Society of Electrolyte Metabolism
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6414314/ https://ncbi.nlm.nih.gov/pubmed/30899311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5049/EBP.2018.16.2.23 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|